Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?

• Authors: Lawrence H Einhorn, Richard S Foster
• Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (J Clin Oncol) Vol. 24 Issue 16 Pg. 2597-8; author reply 2598-9 (Jun 01 2006) ISSN: 1527-7755 [Electronic] United States
• PMID: 16735718 (Publication Type: Comment, Letter)

Chemical References

• Bleomycin
• Etoposide
• Cisplatin

Topics

• Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
• Bleomycin (administration & dosage)
• Cisplatin (administration & dosage)
• Drug Administration Schedule
• Etoposide (administration & dosage)
• Humans
• Male
• Neoplasms, Germ Cell and Embryonal (drug therapy)
• Risk Assessment
• Risk Factors